A 72-year-old woman with well-controlled hypertension and osteoarthritis presents for preventive care. She has never had fragility fractures. According to the 2023 CTFPHC fragility fracture screening guideline, which approach is most appropriate?AOrder a bone mineral density test for all women over 65 without risk assessmentBAssess fracture risk using FRAX then decide on bone mineral density testing and pharmacotherapyCDo not assess fracture risk because she has no fracturesDStart bisphosphonate therapy empirically based on age aloneEMeasure serum vitamin D only to assess fracture riskCheck my answer